Related Experiment Videos
Cardiotolerance of iohexol. Survey of experimental evidence
Insights
Nonionic contrast media, like iohexol, demonstrate fewer cardiovascular complications than ionic agents, such as diatrizoate. This finding is crucial for improving patient safety during angiocardiography procedures.
Area of Science:
- Cardiovascular Pharmacology
- Radiological Imaging Agents
Background:
- Contrast media used in angiocardiography can cause significant cardiovascular complications.
- Effects include electrophysiologic, hemodynamic, and metabolic disturbances.
Purpose of the Study:
- To compare the central cardiovascular effects of nonionic contrast media (iohexol) versus ionic contrast media (diatrizoate).
Main Methods:
- Controlled animal experiments were conducted to assess cardiovascular function.
- Specific parameters evaluated included electrophysiology, hemodynamics, and interactions with other medications.
Main Results:
- Nonionic media showed a lower propensity for ventricular arrhythmias and bradycardia compared to ionic media.
- Nonionic iohexol did not adversely affect left ventricular function or interact with verapamil, unlike ionic diatrizoate.
- Iohexol did not increase lung water or femoral blood flow, whereas diatrizoate did.
Conclusions:
- Nonionic contrast media, specifically iohexol, exhibit fewer and less severe negative effects on central cardiovascular function than standard ionic media.
- These findings support the use of nonionic agents for enhanced patient safety in angiocardiography.
Abstract:
The risk of significant complications from contrast media is greatest in angiocardiography. Contrast media effects on central cardiovascular function include electrophysiologic effects such as bradycardia, hypotension, and ventricular arrhythmias; hemodynamic effects such as hypotension and blood flow changes; and metabolic effects such as transient hypocalcemia. Differences between ionic and nonionic media are less obvious in clinical studies but become apparent in carefully controlled animal experiments. Evidence indicates that nonionic media have less propensity to cause ventricular arrhythmias and bradycardia than ionic media. In addition, nonionic agents do not adversely affect left ventricular regional function and produced no negative inotropic effects in the presence of coronary stenosis. Unlike ionic diatrizoate, nonionic iohexol did not significantly interact with the calcium blocker, verapamil. Iohexol also produced no increase in lung water or in femoral blood flow, while diatrizoate produced increases in both. It is concluded that iohexol has fewer and less severe negative effects on central cardiovascular function than standard ionic media.